Literature DB >> 33864968

The C Factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology.

Amitai Abramovitch1, Tatiana Short2, Avraham Schweiger3.   

Abstract

Research into cognitive functions across psychological disorders suggests that cognitive deficiencies may be present across multiple disorders, potentially pointing to a transdiagnostic phenomenon. More recently, a single dimension model of psychopathology, the p factor, has been proposed, in which cognitive deficits are thought to be an intrinsic construct, assumed to be transdiagnostic. However, no systematic investigation to date tested this hypothesis. The aim of the present study was to systematically review meta-analyses to assess the hypothesis that the C factor (cognitive dysfunction) is transdiagnostic in psychopathology and review potential moderators that may account for such a phenomenon. We conducted a systematic review of meta-analyses examining cognitive function across all disorders for which data were available. Included meta-analyses (n = 82), comprising 97 clinical samples, yielded 1,055 effect sizes. Twelve major disorders/categories (e.g., bipolar disorder, substance use disorders) were included, comprising 29 distinct clinical entities (e.g., euthymic bipolar disorder; alcohol use disorder). Results show that all disorders reviewed are associated with underperformance across cognitive domains, supporting the hypothesis that the C factor (or cognitive dysfunction) is a transdiagnostic factor related to p. To examine moderators that may explain or contribute to c, we first consider important interpretative limitations of neuropsychological data in psychopathology. More crucially, we review oft-neglected motivational and emotional transdiagnostic constructs of p, as prominent contributing constructs to the C factor. These constructs are offered as a roadmap for future research examining these constructs related to p, that contribute, and may account for cognitive dysfunctions in psychopathology.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Effort; Neuropsychology; Psychopathology; Transdiagnostic; p factor

Year:  2021        PMID: 33864968     DOI: 10.1016/j.cpr.2021.102007

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  7 in total

1.  Associations between Brain Structural Alterations, Executive Dysfunction, and General Psychopathology in a Healthy and Cross-Diagnostic Adult Patient Sample.

Authors:  Adrienne L Romer; Diego A Pizzagalli
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-06-12

Review 2.  Neurocognitive functioning in bipolar disorder: What we know and what we don't.

Authors:  Kamyar Keramatian; Ivan J Torres; Lakshmi N Yatham
Journal:  Dialogues Clin Neurosci       Date:  2022-06-01

3.  Investigating the Link Between Depression, Cognition, and Motivation in Late Childhood.

Authors:  David C Steinberger; Deanna M Barch
Journal:  Child Psychiatry Hum Dev       Date:  2021-10-22

4.  Associations between symptom and neurocognitive dimensions in clinical high risk for psychosis.

Authors:  Ingvild Aase; Johannes H Langeveld; Inge Joa; Jan Olav Johannessen; Ingvild Dalen; Wenche Ten Velden Hegelstad
Journal:  Schizophr Res Cogn       Date:  2022-06-02

5.  Neuropsychological Performance Among Individuals at Clinical High-Risk for Psychosis vs Putatively Low-Risk Peers With Other Psychopathology: A Systematic Review and Meta-Analysis.

Authors:  Zachary B Millman; Caroline Roemer; Teresa Vargas; Jason Schiffman; Vijay A Mittal; James M Gold
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

6.  Life Satisfaction Prevents Decline in Working Memory, Spatial Cognition, and Processing Speed: Latent Change Score Analyses Across 23 Years.

Authors:  Nur Hani Zainal; Michelle G Newman
Journal:  Eur Psychiatry       Date:  2022-04-19       Impact factor: 7.156

Review 7.  Metacognitive training for psychosis (MCT): past, present, and future.

Authors:  Steffen Moritz; Mahesh Menon; Ryan Balzan; Todd S Woodward
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-25       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.